Prof Kostas Tokatlidis (Cathcart Chair of Biochemistry, University of Glasgow) and Dr Keith Wreggett (Biotech Consultant, InnoSpective) discuss the Mitotargin Project; an innovative translational project to develop therapeutic and diagnostic applications through research into the mitochondria.
For more information, please see our webpages:
Prof Tokatlidis https://www.gla.ac.uk/schools/molecularbiosciences/staff/kostastokatlidis/
UofG College of Medical, Veterinary and Life Sciences, Translational Research Initiative: https://www.gla.ac.uk/colleges/mvls/researchinnovationengagementsupport/tri/
UofG IP and Commercialisation Team: https://www.gla.ac.uk/myglasgow/ris/ipcommercialisation/#:~:text=The%20IP%20%26%20Commercialisation%20team%20provide,and%20execute%20agreed%20exploitation%20plans.
Further Information on Translational Projects: https://www.gla.ac.uk/colleges/mvls/researchinnovationengagementsupport/tri/casestudies/
Mitotargin Translational Project funded through the Wellcome Trust Translational Partnership Award, grant ref. 219390/Z/19/Z, BBSRC Impact Accelerator Account ref. BB/S506734/1, MRC Proximity to Discovery award ref. MC_PC_17190 and MRC Confidence in Concept Award, grant ref. MC_PC_18048 and MC_PC_19039.
source
